8-KLeadership Changes

EXXON MOBIL CORP 8-K Report, Executive Changes (Jan 30, 2008)

Filed January 30, 2008For Securities:XOM

Summary

Exxon Mobil Corporation (XOM) announced on January 30, 2008, a change to its Board of Directors. The company elected Dr. Larry R. Faulkner as a new non-employee director. Dr. Faulkner brings experience from his roles as President of Houston Endowment Inc. and President Emeritus of the University of Texas at Austin. This appointment is effective immediately following the Board of Directors' meeting on the same date. Dr. Faulkner has been appointed to serve on key board committees, including the Audit Committee and the Finance Committee, and will also be an alternate member of the Executive Committee. These committee assignments suggest the board is seeking to leverage Dr. Faulkner's expertise in financial oversight and strategic planning. Investors should note this as a board refreshment event, potentially bringing new perspectives to the company's governance.

Key Highlights

  • 1Exxon Mobil Corporation (XOM) elected Larry R. Faulkner as a new non-employee director to its Board of Directors.
  • 2The appointment was made at a Board of Directors meeting on January 30, 2008.
  • 3Dr. Faulkner's current affiliations include President of Houston Endowment Inc. and President Emeritus of the University of Texas at Austin.
  • 4Dr. Faulkner has been appointed to the Audit Committee of the Board.
  • 5Dr. Faulkner has also been appointed to the Finance Committee of the Board.
  • 6He will serve as an alternate member of the Executive Committee.
  • 7This filing is an 8-K, indicating a significant event relevant to shareholders.

Frequently Asked Questions

Larry R. Faulkner is a non-employee director appointed to Exxon Mobil's Board. He brings experience from his leadership roles at Houston Endowment Inc. and the University of Texas at Austin. His appointment likely aims to enhance the board's expertise, particularly in areas related to financial oversight and strategic direction, given his committee assignments.

Dr. Faulkner has been appointed to the registrant's Audit Committee and Finance Committee. He will also serve as an alternate member of the Executive Committee.

Typically, the addition of experienced directors to a board is viewed neutrally to positively, as it can bring fresh perspectives and strengthen governance. Dr. Faulkner's background suggests he could provide valuable insights to the Audit and Finance committees, which are critical for investor confidence. Investors should monitor his contributions over time.

An 8-K filing is a report of "unscheduled material events or corporate changes" that investors should know about. This specific 8-K reports on a significant change in the company's board of directors, which is information material to shareholders.